GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

GC Genome 340450.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

6,770

-2.03%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About GC Genome

Its shares trade on KOSDAQ under the ticker 340450.KQ. It has been listed since 11 June 2025. In the fiscal year to 31 December 2025, it reported revenue of ₩31.53bn and net income of ₩4.04bn. At that date it held total assets of ₩84.63bn and shareholders' equity of ₩78.27bn.

GC Genome Corp. is a clinical genome analysis company, which engages in specializing clinical genome analysis. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2025-06-11. The firm is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
11 Jun 2025
Employees
125

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • GC Genome Corp specializes in clinical genome analysis services.
  • The company provides prenatal and newborn screening genetic testing.
  • It offers precision diagnosis services for cancer and rare disease patients.

Weaknesses

  • The firm is headquartered in Yongin, Gyeonggi-Do.
  • It currently employs 125 full-time employees.
  • The company went public on 2025-06-11.

Opportunities

  • The ticker symbol is 340450.KQ on the Korean market.
  • The ISIN code is KR7340450006 for international identification.
  • The website https://www.gcgenome.com/ serves as a digital presence.

Threats

  • The sector is classified as Health Care.
  • The industry is defined as Biotechnology.
  • The country of operation is KR.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.